Washington State University

MissionSquare Retirement Announces Retirement of Chief Investment Officer Wayne Wicker Following Distinguished Financial Services Career

Retrieved on: 
Tuesday, April 2, 2024
CIO, Health, Retirement, ESG, University, Head, Wicker, MBA, Washington State University, Investment, CFA, CAIA, National university, Financial adviser

Washington D.C., April 02, 2024 (GLOBE NEWSWIRE) -- MissionSquare Retirement , a staunch advocate of retirement security and financial well-being, today announces the retirement of Wayne Wicker, the company’s highly respected Chief Investment Officer (CIO).

Key Points: 
  • Washington D.C., April 02, 2024 (GLOBE NEWSWIRE) -- MissionSquare Retirement , a staunch advocate of retirement security and financial well-being, today announces the retirement of Wayne Wicker, the company’s highly respected Chief Investment Officer (CIO).
  • Karen Chong-Wulff , CFA, CAIA, Head of Fixed Income for MissionSquare Retirement, will succeed Wicker as Acting CIO, effective April 5, 2024, in accordance with the company’s succession plan.
  • “MissionSquare Retirement is grateful for Wayne’s twenty years of service to the company, and we wish him the very best in his well-deserved retirement,” said Deanna J. Santana, Acting CEO & President at MissionSquare Retirement.
  • Prior to joining MissionSquare Retirement in July 2007, Chong-Wulff held senior positions at DuPont Capital Management and Morley Capital Management.

Stephanie Burke Named as VGXI's New Chief Accounting Officer

Retrieved on: 
Wednesday, March 27, 2024
Finastra, CDMO, Business administration, Accounting, MRP, RNA, DNA, Washington State University, Material, Comptroller, Management

Ms. Burke joined the company in 2015 bringing with her over a decade of accounting and leadership expertise and has since played an instrumental role in the company's financial operations.

Key Points: 
  • Ms. Burke joined the company in 2015 bringing with her over a decade of accounting and leadership expertise and has since played an instrumental role in the company's financial operations.
  • Ms. Burke has previously held leadership roles overseeing both the VGXI Accounting/Finance and Materials teams.
  • "I am honored to take on the position of Chief Accounting Officer," said Ms. Burke.
  • Her exceptional financial acumen coupled with her leadership skills make her the ideal candidate for the Chief Accounting Officer position.

Arlo Announces Changes to Executive Leadership Team to Drive Expansion of Consumer-Oriented, Services-First Strategy

Retrieved on: 
Thursday, February 29, 2024
Consumer Electronics, Technology, Construction & Property, IOT (Internet of Things), Building Systems, Other Technology, Software, Artificial Intelligence, Audio, Video, Mobile, Wireless, Hardware, CFO, Engineering, Arlo Technologies, Fitbit, Culture, Growth, MBA, University, Bombay Company, Doctor of Philosophy, Software as a service, Organization, Acceleration, Electricity, Washington State University, Management

Samir is a seasoned C-level technology executive with deep experience leading complex engineering organizations across hardware, software, and SaaS technology companies.

Key Points: 
  • Samir is a seasoned C-level technology executive with deep experience leading complex engineering organizations across hardware, software, and SaaS technology companies.
  • With a proven track record of success at companies including Fitbit and Life360, where he also served as Chief Technology Officer, Samir’s appointment will further strengthen Arlo’s executive leadership team as it focuses on the acceleration of its services-first strategy.
  • “As Arlo looks forward to its next stage of growth, we are excited to welcome Samir into Arlo’s executive leadership as its new Chief Technology Officer,” said Matthew McRae, Arlo CEO.
  • “I am thrilled to join the Arlo leadership team and leverage my consumer-centric, services-first experience to accelerate the execution of Arlo’s services-first strategy, increase customer satisfaction, and maximize shareholder value,” said Samir Kapoor.

Kiara Education Solution Pvt. Ltd. Announces Dr. (Hon) Jyotsna Behl's Felicitation at the House of Lords in London

Retrieved on: 
Tuesday, March 5, 2024
House of Lords, NSUT, International Coaching Federation, Entrepreneurship, Multimedia, Education, Ego, Culture, G-20, Welfare, Growth, Hope, MBA, Confluence, KES, Jawaharlal Nehru University, Intellect, TED (conference), World Health Organization, Gold, House, Gold medal, Happiness, Raj Loomba, Baron Loomba, Wellness, ICF, Personal development, Memory, Washington State University, Face, CTA

NEW DELHI, March 4, 2024 /PRNewswire-PRWeb/ -- Kiara Education Solution Private Limited (KES), a leader in the domain of happiness coaching, employee engagement, and well-being training, is thrilled to reveal the felicitation of its CEO, Dr. (Hon) Jyotsna Behl, in the prestigious House of Lords, London. Jyotsna was felicitated on February 17th, by Bharat Gaurav Samman at Bharat Mahotsav organized by Confluence and hosted by The Loomba Foundation, The Felicitations done by The chief guest Dr. Sandhya Purecha Chairperson Sangeet Natak Academy Ministry of culture and chairperson W-20 of G-20 .and the gracious presence of Lord Loomba CBE. Jyotsna graciously received a certificate that comes as a recognition of her outstanding contributions as a Happiness Coach and her impact on social welfare as a Life Transformation Facilitator and Soft Skills Trainer.

Key Points: 
  • Bharat Mahotsav London 2024, also served as the stage for announcing Jyotsna's latest book cover "EgoGym For Billionaires".
  • This eagerly anticipated book "EgoGym for Billionaires" explores the essence of ego, providing insights into its origins and impactful role in personal growth.
  • Jyotsna shares the secrets to monumental success, encouraging readers to break free from their comfort zones, reshape their self-image, and cultivate a positive ego.
  • Jyotsna Behl, Kiara Education Solutions Pvt Ltd, New Delhi, +919910097974, [email protected] , http://www.kiaraedu.com
    View original content to download multimedia: https://www.prweb.com/releases/kiara-education-solution-pvt-ltd-announce...
    SOURCE Kiara Education Solutions Pvt Ltd, New Delhi

Argonne and other institutions report first-ever atomic freeze frame of liquid water

Retrieved on: 
Friday, February 16, 2024
White House, Federal Government, Aerospace, Energy, Manufacturing, Technology, University, Radiology, Nuclear, Education, Public Policy, Government, Other Technology, Science, Other Science, Other Energy, Research, Health, Pacific Northwest National Laboratory, Electron, Nobel Prize in Physics, University of Chicago, James Franck Institute, Radiation, Argonne National Laboratory, Void coefficient, SLAC National Accelerator Laboratory, History, University of Washington, Movement, Washington State University, Nobel Prize

Their study, recently published in the journal Science , built on the new science of attosecond physics, recognized with the 2023 Nobel Prize in Physics.

Key Points: 
  • Their study, recently published in the journal Science , built on the new science of attosecond physics, recognized with the 2023 Nobel Prize in Physics.
  • The study sample was a stream of liquid water, chosen as a model molecule in this first-ever experiment.
  • This allowed them to take a fingerprint of the electronic response following ionization in liquid water, all before the bulkier hydrogen atoms have time to move.
  • The findings demonstrate that a longstanding measurement of the structure of liquid water has been misinterpreted.

YS Biopharma Announces Appointment of New Directors

Retrieved on: 
Wednesday, February 14, 2024
CFO, Peking University, Doctor of Philosophy, Project, Legal Affairs, Wanda Group, MBA, Vaccine, General counsel, Shanxi University, Interim, Chairperson, Comptroller, University, Partner, Business administration, Renmin University of China, Biomedical sciences, Business, JD, Ernst & Young, Worcester Polytechnic Institute, International law, Infection, Chemical engineering, YS, DXY, Washington State University, Cancer, Management

GAITHERSBURG, Md., Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024.

Key Points: 
  • GAITHERSBURG, Md., Feb. 14, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024.
  • Ms. Chunyuan (Brenda) Wu currently serves as the CFO of YS Group, a position she has held since December 31, 2020.
  • Previously, Ms. Wu served as CFO of YS Group Biopharma from 2018-2020, and as Financial Controller for the same company from 2013-2018.
  • Dr. Ajit Shetty, Chairperson of the Board of Directors of the Company, commented, "We are pleased to welcome each of our new directors to the Board.

Mindful Therapy Group Enters Arizona Market with Tempe Office Officially Opening in May

Retrieved on: 
Tuesday, February 13, 2024
Fort Collins, Colorado, Anxiety, Mental health, Washington State University, Mindfulness, Growth, Mental, LICSW, Depression

MOUNTLAKE TERRACE, Wash., Feb. 13, 2024 /PRNewswire/ -- Today, Mindful Therapy Group (Mindful), a collaborative network of licensed, independent mental health clinicians, announced its expansion into the Arizona market. The new office based in Tempe will officially open in May 2024 and is located near the Arizona State University Tempe campus at 1250 W Washington St #215. Prior to the office opening, clinicians are now seeing Arizona residents via telehealth.  

Key Points: 
  • MOUNTLAKE TERRACE, Wash., Feb. 13, 2024 /PRNewswire/ -- Today, Mindful Therapy Group (Mindful) , a collaborative network of licensed, independent mental health clinicians, announced its expansion into the Arizona market.
  • The new office based in Tempe will officially open in May 2024 and is located near the Arizona State University Tempe campus at 1250 W Washington St #215.
  • Prior to the office opening, clinicians are now seeing Arizona residents via telehealth.
  • For individuals seeking immediate access to telehealth services in Arizona and/or for more information about Mindful Therapy Group, visit mindfultherapygroup.com.

Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic

Retrieved on: 
Wednesday, February 7, 2024
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, Washington State University, Neoplasm, Knowledge, Metabolism, Therapy, Safety, Patient, CB21, Publication, Drug discovery, Spacecraft, University, University of Northern Colorado, Amgen, Pharmaceutical industry

Cartography Biosciences , an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Dan Rock, Ph.D., as Chief Scientific Officer.

Key Points: 
  • Cartography Biosciences , an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Dan Rock, Ph.D., as Chief Scientific Officer.
  • In this role, Dr. Rock will be responsible for guiding the company’s scientific strategy and leading efforts to advance Cartography’s internal programs into the clinic.
  • “As Cartography moves into the next phase of development focused on advancing our internal pipeline discovered from our Atlas platform, we are thrilled to welcome Dan to the team.
  • “I’m honored to be joining a team at the forefront of innovation and I look forward to leading the team as Chief Scientific Officer in the pursuit of better treatment options for patients with cancer.”

Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis

Retrieved on: 
Sunday, February 4, 2024
ALP, AGAF, IBD, Ascending cholangitis, Liver failure, Pharmacokinetics, SAN, Washington State University, Inflammation, Fibrosis, Cirrhosis, Itch, PSC, Ursodeoxycholic acid, MRI, Telephone, Magnetic resonance imaging, Inflammatory bowel disease, Patient, Safety, FDA, EMA, FACP, Disease, IPF, SAE, FRCP, ELF, Week, Therapy, Conference call, Alkaline phosphatase, Interest, UDCA, FACG, University, Webcast, Liver, Primary sclerosing cholangitis, Plasma, Liver disease, Conference, Medical imaging

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced 12-week interim data from the 320 mg dose group of INTEGRIS-PSC, a multinational, randomized, double-blind, placebo-controlled Phase 2a clinical trial of bexotegrast in patients with primary sclerosing cholangitis (PSC) and suspected moderate to severe liver fibrosis. The 320 mg group met its primary and secondary endpoints demonstrating that bexotegrast was well tolerated over a 12-week treatment period and its plasma concentrations increased with dose. There was no dose relationship for adverse events. Pruritus and cholangitis occurred less frequently on bexotegrast than on placebo.

Key Points: 
  • The trial’s exploratory efficacy endpoints assessed changes in the liver fibrosis markers, Enhanced Liver Fibrosis (ELF) score and PRO-C3 levels, as well as liver biochemistry and magnetic resonance imaging (MRI) of the liver.
  • In addition, MRI imaging continued to show evidence of improved hepatocyte function and bile flow with bexotegrast at the 320 mg dose relative to placebo.
  • INTEGRIS-PSC is a multinational, randomized, dose-ranging, double-blind, placebo-controlled Phase 2a trial evaluating bexotegrast at once-daily oral doses of 40 mg, 80 mg, 160 mg, 320 mg or placebo for 12 weeks in 121 patients with PSC.
  • The 320 mg group enrolled 27 patients in the active arm and added 9 new patients to the pooled placebo arm.

Expanding Our Scope: Working Forest Carbon Blueprint Unveils Comprehensive Strategy for Carbon Management and Sustainable Forestry

Retrieved on: 
Wednesday, January 17, 2024
Carbon, CO2, Farmer, Wood, Sustainability, American Wood Council, Food, Forestry, Insurance, Washington State University, Pacific Northwest, Atmosphere, Washington State, Climate change, Water, Tree, Safety, Building material, WFPA, Climate, Timber, Education

OLYMPIA, Wash., Jan. 17, 2024 /PRNewswire/ -- The Washington Forest Protection Association (WFPA) proudly announces the Working Forest Carbon Blueprint website launch.

Key Points: 
  • OLYMPIA, Wash., Jan. 17, 2024 /PRNewswire/ -- The Washington Forest Protection Association (WFPA) proudly announces the Working Forest Carbon Blueprint website launch.
  • "Through the Working Forest Carbon Blueprint, the forest sector is working together to provide state policymakers with real and effective solutions for combatting climate change, said Travis Joseph, President, American Forest Resource Council.
  • Through sustainable forest management, we can enhance forest health, increase carbon storage in wood products, and contribute significantly to Washington's climate goals."
  • To learn more about the Working Forest Carbon Blueprint and the multifaceted approach to sustainable forestry and carbon management, visit www.WAForestCarbon.com .